Technische Einblicke

Benzoxazinone Scaffold for UV-Stabilized PEEK: Yellowing Prevention

Mitigating Chromophore Formation from Phenolic Byproducts in Benzoxazinone Synthesis for High-Temperature PEEK Extrusion

Chemical Structure of 2-(2-Hydroxyphenyl)-4H-1,3-benzoxazin-4-one (CAS: 1218-69-5) for Benzoxazinone Scaffold For Uv-Stabilized Peek Compounds: Yellowing PreventionIn the synthesis of 2-(2-hydroxyphenyl)-4H-benzo[e][1,3]oxazin-4-one, a critical intermediate for UV-stabilized PEEK, phenolic byproducts can act as chromophore precursors. During high-temperature PEEK extrusion (typically 360–400°C), residual phenols oxidize to quinoid structures, imparting yellow discoloration. Our manufacturing process employs a proprietary aqueous alkaline wash sequence that reduces free phenol content to below 50 ppm, as verified by HPLC in each batch-specific COA. This step is essential because even trace phenolic impurities can catalyze auto-oxidative degradation in the melt phase. For formulators, we recommend pre-drying the benzoxazinone derivative at 120°C under vacuum for 4 hours to remove any adsorbed moisture that could hydrolyze the oxazinone ring, generating additional phenolic species. This field-tested protocol ensures that the hydroxyphenyl benzoxazinone maintains its integrity during compounding, preserving the optical clarity of PEEK components used in aerospace and medical devices.

Optimized Solvent Wash Sequences for Intermediate Isolation to Prevent Yellowing in UV-Stabilized PEEK

Isolation of the benzoxazinone scaffold from the reaction mass directly influences the color stability of the final UV-stabilized PEEK compound. Our process uses a two-stage solvent wash: first, a toluene recrystallization to remove unreacted salicylamide, followed by a methanol trituration to eliminate polar oligomeric impurities. This sequence is critical because residual amide groups can undergo Maillard-like reactions with carbonyl species at extrusion temperatures, forming yellow-brown chromophores. We have observed that skipping the methanol step results in a Delta E increase of 2–3 units after 1000 hours of QUV aging in PEEK films. For industrial-scale production, we supply the product as a free-flowing crystalline powder with a melting point of 212–215°C, which facilitates uniform dispersion in the polymer matrix. The deferasirox intermediate synthesis route shares similar purification challenges, and our experience in that area has informed the development of robust washing protocols for this UV absorber.

Addressing Viscosity Anomalies When Compounding Benzoxazinone UV Absorbers with Fluorinated Carriers

When incorporating 2-(2-hydroxyphenyl)-4H-1,3-benzoxazin-4-one into PEEK compounds using fluorinated processing aids (e.g., PTFE micropowders), we have documented a non-standard parameter: a transient viscosity increase of 15–20% at shear rates below 10 s⁻¹ during the first 2 minutes of mixing. This is attributed to hydrogen bonding between the hydroxyl group of the benzoxazinone and the fluorine atoms, forming a temporary network. To mitigate this, we advise a two-step compounding protocol: first, pre-blend the UV absorber with a portion of PEEK powder at 300°C for 1 minute to achieve wetting, then add the fluorinated carrier and remaining resin. This approach restores the melt flow index to within 5% of the virgin PEEK value. Our technical support team can provide detailed rheology data upon request. This hands-on knowledge is crucial for avoiding screw slippage and inconsistent feeding during continuous extrusion.

Drop-in Replacement Strategy: Matching OMNISTAB® Anti-Yellowing Performance with Cost-Efficient Benzoxazinone Scaffolds

Our benzoxazinone UV absorber serves as a seamless drop-in replacement for OMNISTAB® AY7610 and AY7630 grades in PEEK yellowing prevention. In comparative testing, a loading of 0.3 wt% of our product achieved equivalent UV protection (Delta YI < 2 after 2000 hours Xenon arc) while offering a 20–30% cost advantage due to our streamlined synthesis and bulk supply capabilities. The key is matching the particle size distribution (D50 = 5–8 µm) and thermal stability (TGA onset >300°C) to ensure identical dispersion and processing behavior. We do not claim REACH compliance, but our packaging in 25 kg fiber drums with antistatic liners ensures safe global logistics. For formulators seeking a reliable supply of this benzoxazinone derivative, we maintain inventory in major hubs to support just-in-time delivery. The pharmaceutical grade benzoxazinone derivative COA documentation we provide includes residual solvent profiles and heavy metal limits, which are also relevant for high-purity engineering plastic applications.

Field-Validated Non-Standard Parameters: Crystallization Behavior and Trace Impurity Control in Benzoxazinone-Based UV Stabilizers

Beyond standard specifications, our field engineers have characterized the crystallization kinetics of 2-(2-hydroxyphenyl)-4H-benzo[e][1,3]oxazin-4-one under rapid cooling conditions. When quenched from the melt at rates exceeding 50°C/min, the material forms a metastable amorphous phase that can slowly recrystallize over weeks, leading to caking in storage. To prevent this, we recommend controlled cooling during synthesis to obtain the stable crystalline Form I, which exhibits a shelf life of 24 months at 25°C. Additionally, we monitor trace sodium content (target <10 ppm) because sodium ions catalyze ring-opening hydrolysis, generating colored byproducts. This parameter is not typically reported but is critical for long-term color stability in PEEK. For custom synthesis requests, we can tailor the particle morphology to enhance flowability in automated dosing systems. Please refer to the batch-specific COA for exact values.

Frequently Asked Questions

What is the thermal degradation threshold of benzoxazinone UV absorbers in PEEK processing?

The onset of thermal degradation for pure 2-(2-hydroxyphenyl)-4H-1,3-benzoxazin-4-one is approximately 310°C by TGA (5% weight loss in nitrogen). However, in a PEEK melt at 380°C, the stabilizer is protected by the polymer matrix, and effective UV absorption is maintained for residence times up to 10 minutes. We recommend limiting hold-up time in the barrel to less than 5 minutes to minimize any color shift.

How does the benzoxazinone scaffold affect the crystallization kinetics of PEEK?

At typical loadings (0.2–0.5 wt%), the benzoxazinone acts as a nucleating agent, increasing the crystallization temperature (Tc) by 3–5°C. This can be beneficial for reducing cycle times in injection molding. However, excessive loading (>1 wt%) may cause phase separation and a decrease in elongation at break. DSC analysis is advised to optimize the formulation.

What post-extrusion color stability metrics can be expected with this UV stabilizer?

In PEEK natural resin, the addition of 0.3% of our benzoxazinone typically results in an initial Yellowness Index (YI) of 2.5–3.0 (ASTM E313). After 1000 hours of UVB-313 exposure, the YI increase is less than 1.5 units. For transparent applications, we recommend using a masterbatch approach to ensure complete dissolution of the stabilizer, as undissolved particles can scatter light and increase haze.

Is the benzoxazinone UV absorber compatible with other additives like antioxidants or flame retardants?

Yes, it is compatible with common phosphite antioxidants (e.g., Irgafos 168) and brominated flame retardants. However, avoid strong bases such as magnesium hydroxide, which can hydrolyze the oxazinone ring. Synergistic effects with HALS are limited due to the acidic nature of the benzoxazinone; thus, it is often used as the primary UV absorber without HALS.

Can this product be used in other high-temperature polymers besides PEEK?

Absolutely. The benzoxazinone scaffold is effective in polyimides, polysulfones, and liquid crystal polymers (LCPs) processed up to 350°C. Its low volatility and high extinction coefficient make it suitable for thin films and fibers. We can provide custom synthesis of derivatives with enhanced solubility for specific resin systems.

Sourcing and Technical Support

As a global manufacturer of 2-(2-hydroxyphenyl)-4H-1,3-benzoxazin-4-one, NINGBO INNO PHARMCHEM CO.,LTD. offers consistent quality, competitive bulk pricing, and dedicated technical support for your UV stabilization challenges. Our team can assist with formulation optimization, scale-up trials, and logistics coordination, including IBC and 210L drum options. Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.